VEGFA and metabolic dysfunction-associated steatohepatitis: Although various studies have reported an upregulation of angiogenic factors, particularly VEGF in NASH, the underlying mechanisms that regulate angiogenesis, inflammation and fibrogenesis in NASH pathology remain obscure [5,6,7].